GLOX THERAPEUTICS LIMITED
Active - Accounts Filed
General Information
NAME
GLOX THERAPEUTICS LIMITED
COMPANY NUMBER
SC760230
COMPANY TYPE
Private limited with Share Capital
BUSINESS ACTIVITY (SIC)
72110 -
Research and experimental development on biotechnology
INCORPORATION DATE
27/02/2023
(1 years and 9 months old)
WEBSITE
N/A
CONFIRMATION STATEMENT MADE UP TO
26/02/2024
ACCOUNTS MADE UP TO
31/12/2023
KEEP INFORMED
You are not receiving notifications about this company.
PREVIOUS NAMES
This company does not have any previous names.
GLASGOW
G4 0RE
John Arbuthnott Building
161 Cathedral Street
GLASGOW
G4 0RE
11 University Avenue The Square
Glasgow
Lanarkshire
G12 8QQ
Credit Risk Overview
Want to learn more about GLOX THERAPEUTICS LIMITED?
Purchase the company report or an
Annual Subscription
to view this information.
CREDIT RISK
N/APurchase to view all Since 01/01/1970 |
CREDIT LIMIT
£0 GBPSince 01/01/1970 |
COUNTY COURT JUDGEMENTS
1In Judgement £0Total Requested 1Satisfied £0Total paid |
Documents
| Date Filed | Description | Download | Group |
|---|---|---|---|
| Company does not have any documents. | |||
Group Structure Overview
| Company Name | Status | Report |
|---|---|---|
| This company does not have a group structure. | ||
Timeline Overview
| Date | Event |
|---|---|
| 09/10/2024 | New Board Member James Scott Clark (914043581) Appointed |
| 21/08/2024 | Melville Anderson (930602558) has left the board |
| 27/03/2024 | New Confirmation Statement filed |
Credit Risk Overview
Want to learn more about GLOX THERAPEUTICS LIMITED?
Purchase the company report or an
Annual Subscription
to view this information.
CREDIT RISK
N/APurchase to view all Since 01/01/1970 |
CREDIT LIMIT
£0 GBPSince 01/01/1970 |
COUNTY COURT JUDGEMENTS
1In Judgement £0Total Requested 1Satisfied £0Total paid |
Credit Health History
Want to learn more about GLOX THERAPEUTICS LIMITED?
Purchase the company report or an
Annual Subscription
to view this information.
Want to learn more about GLOX THERAPEUTICS LIMITED?
Purchase the company report or an
Annual Subscription
to view this information.
| Date | Court | Case No. | Amount | Status | Date Paid |
|---|---|---|---|---|---|
| 01/01/1970 | SAMPLE, PURCHASE TO VIEW | SAMPLE00 | £ N/A | Satisfied | N/A |
| 01/01/1970 | SAMPLE, PURCHASE TO VIEW | SAMPLE00 | £ N/A | In Judgement | N/A |
Accounts
Shareholders
Directors & Secretaries
| Personal Information | Status | Position | Appointments | Report |
|---|---|---|---|---|
|
27/02/2023 - Present (1 years and 9 months) Born in Nov 1968 (age: 56) |
Active | Director |
Current: 1 Past: 0 |
View Report |
|
27/02/2023 - Present (1 years and 9 months) Born in N/A |
Active | Secretary |
Current: 1 Past: 0 |
View Report |
|
27/02/2023 - Present (1 years and 9 months) Born in Nov 1968 (age: 56) |
Active | Director |
Current: 2 Past: 4 |
View Report |
|
24/10/2023 - Present (1 years and 1 months) Born in May 1976 (age: 48) |
Active | Director |
Current: 1 Past: 0 |
View Report |
|
24/10/2023 - Present (1 years and 1 months) Born in Feb 1973 (age: 51) |
Active | Director |
Current: 1 Past: 0 |
View Report |
Documents
| Date Filed | Description | Download | Group |
|---|---|---|---|
| Company does not have any documents. | |||
Group Structure Overview
| Company Name | Status | Report |
|---|---|---|
| This company does not have a group structure. | ||
Timeline Overview
| Date | Event |
|---|---|
| 09/10/2024 | New Board Member James Scott Clark (914043581) Appointed |
| 21/08/2024 | Melville Anderson (930602558) has left the board |
| 27/03/2024 | New Confirmation Statement filed |
| 22/01/2024 | New Board Member Daniel Walker (930902503) Appointed |
| 22/01/2024 | New Board Member Niklas Czeloth (931825052) Appointed |
Free Credit Score Toolkit
Make better business decisions
Get helpful tips on how to use company credit reports when making potentially critical business choices.
- How to find out who’s really behind the business with director and shareholder information
- What a credit score means and the factors that affect your own company’s credit rating
- Which financial figures are key when assessing a potential partner or supplier
